2nd Quarter - Report

TARPLIN, DOWNS & YOUNG, LLC for ELI LILLY AND COMPANY

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 H.R. 3 - Lower Drug Costs Now Act S. 2543 - Prescription Drug Pricing Reduction Act no specific bills, Medicare Part D, Value based purchasing, Medicare Part B, 340B, Medicare coverage & reimbursement, insulin, Senate and Finance Drug bill

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 2543 (116th), H.R. 1839 (116th), H.R. 3 (116th)

Health Issues HCR

S. 1416 - Affordable Prescriptions For Patients Act of 2019 S. 1895 - Lower Health Care Costs Act H.R. 3 - Lower Drug Costs Now Act S. 2543 - Prescription Drug Pricing Reduction Act S. 3013 - Encouraging Innovative Benefit Design to Lower Costs for Seniors Act S. 3129 - Lower Costs, More Cures Act of 2019 H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 H.R. 6201 - Families First Coronavirus Response Act S. 3548 - CARES Act H.R. 6800 - The Heroes Act no specific bills, non-interference, dormant therapies, drug shortages, prescription drug access and affordability, transparency, insulin policy, authorized generics, 340B

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3 (116th), H.R. 6201 (116th), S. 3129 (116th), S. 1416 (116th), S. 3013 (116th), H.R. 6074 (116th), H.R. 6800 (116th), S. 3548 (116th), S. 2543 (116th), S. 1895 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.